October 2025
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
August 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
August 2026
The global AI in cancer immunotherapy drugs market size was evaluated at USD 2.80 billion in 2025 and is predicted to hit around USD 27.79 billion by 2035, growing at a CAGR of 25.80%.
May 2026
The global cancer biological therapy market size is expected to increase from USD 124.44 billion in 2025 and is predicted to reach at USD 266.75 billion by 2035, with a solid CAGR of 7.99%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
July 2026
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
September 2026
The cryotherapy market was valued at USD 11.18 billion in 2026, with leading companies including Brymill Cryogenic Systems, Metrum Cryoflex, Medtronic plc.
September 2026
The nicotine replacement therapy market generated USD 108.61 billion in 2026, with prominent nicotine replacement therapy companies including Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Glenmark Pharmaceuticals.
September 2026
The CAR-T therapies for blood cancers market generated USD 6.80 billion in 2025, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
August 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
August 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
August 2026
The chemical drug CDMO market size was USD 13.20 billion in 2025, with leading chemical drug CDMO market players including Almac Group, BASF SE, Boehringer Ingelheim, Cipla Limited.
August 2026
The chemical API CDMO market size was USD 16.80 billion in 2025, with leading chemical API CDMO market players including Lonza Group, WuXi AppTec, Samsung Biologics, Boehringer Ingelheim.
August 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
August 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 950.00 million in 2025, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
August 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
August 2026
The ovarian cancer drugs market reached USD 4.09 billion in 2025, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
August 2026
The continuous renal replacement therapy market size was USD 1.71 billion in 2026, with leading continuous renal replacement therapy market players including baxter international inc, nikkiso co. ltd, infomed sa, Medtronic plc, bellco.
August 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
August 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
August 2026
The global cancer registry software market size is expected to increase from USD 94.68 million in 2025 to hit around USD 301.40 million by 2035, with a CAGR of 12.28%.
August 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
August 2026
The global breast cancer market size was estimated at USD 26.23 billion in 2025 and is projected to hit around USD 40.11 billion by 2035 with a CAGR of 4.34%.
August 2026
The cancer biopsy market size is estimated at USD 36.55 billion in 2025 and is expected to hit around USD 196.68 billion by 2035, growing at a CAGR of 18.33%.
August 2026
The India immunotherapy drugs market size accounted for USD 11.8 billion in 2025 and is predicted to touch around USD 73.67 billion by 2035, growing at a CAGR of 20.10%.
August 2026
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com